GLG LLC’s Intra-Cellular Therapies Inc. ITCI Stock Holding History

GLG LLC’s Portfolio ITCI Stock Details ITCI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-12,500	Closed	-$500K	–	596
2015 Q3	$500K	Buy	+12,500	New	+$408K	0.01%	496

Other funds holding ITCI

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

TCM

TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

VAM

Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

GLG LLC's ITCI Position: Q4 2015 in Review

GLG LLC sold out of Intra-Cellular Therapies Inc. (ITCI) in Q4 2015, closing a stake of 12,500 shares — an estimated $500K sold.

GLG LLC first reported a position in ITCI in Q3 2015 and held it in 1 quarter. The position peaked at $500K in Q3 2015. 132 funds tracked by Wall St. Rank hold ITCI as of Q4 2015.

GLG LLC reported no remaining Intra-Cellular Therapies Inc. position as of Q4 2015 after selling out during the quarter.
GLG LLC sold 12,500 Intra-Cellular Therapies Inc. shares in Q4 2015, an estimated $500K.
GLG LLC first reported a position in Intra-Cellular Therapies Inc. in Q3 2015 and held it in 1 quarter.
GLG LLC's Intra-Cellular Therapies Inc. position peaked at $500K in Q3 2015.
132 funds tracked by Wall St. Rank held Intra-Cellular Therapies Inc. as of Q4 2015.

Based on GLG LLC's 13F filing for Q4 2015, filed 16 Feb 2016.